Cite
HARVARD Citation
Azaro, A. et al. (n.d.). 301 First-in-human phase I dose-escalation study of a MET/AXL/FGFR inhibitor, S 49076, in patients with advanced solid tumors. European journal of cancer. pp. S54-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Azaro, A. et al. (n.d.). 301 First-in-human phase I dose-escalation study of a MET/AXL/FGFR inhibitor, S 49076, in patients with advanced solid tumors. European journal of cancer. pp. S54-. [Online].